Investor InformationCorporate GovernanceNews Releases

Senior Management

We encourage you to read the following executive profiles to learn more about our Senior Management team.

DAVID FITZGERALD
President and Chief Executive Officer

FRED B. DINGER, III
Senior Vice President and General Manager, ENT

TODD NEWTON
Executive Vice President, Chief Financial Officer and Chief Operating Officer

JAMES PACEK
Senior Vice President, Global Markets and Sales Operations

BRUCE PROTHRO
Chief Regulatory Officer and Senior Vice President of Quality Systems and Assurance

RICHARD W. REW, II
Senior Vice President, General Counsel, and Secretary
SCOTT SCHAFFNER
Sr Vice President and General Manager, Sports Medicine

GAYLE WILEY
Sr Vice President and Chief Human Resources Officer

JEAN WOLOSZKO, M.D., PH.D.
Chief Technology Officer and Senior Vice President of Research and Development

Directors

FABIANA LACERCA-ALLEN
Director

CHRISTIAN P. AHRENS
Director

GREGORY A. BELINFANTI
Director

BARBARA D. BOYAN
Director

DAVID FITZGERALD
Director
President and Chief Executive Officer


JAMES FOSTER
Director

TERRENCE GEREMSKI
Director

TORD B. LENDAU
Director

PETER L. WILSON
Director






FRED B. DINGER, III
Senior Vice President and General Manager, ENT

Fred Dinger joined the Company in July 2013 when ArthroCare acquired Entrigue Surgical, Inc. Mr. Dinger was President and CEO of Entrigue from 2007 to 2013. Prior to ENTrigue, he served as President and CEO at C2M Medical and OsteoBiologics, Vice President and Chief Operating Officer at A-Med Systems, Vice President of Research and Development at Xomed Surgical Products and Linvatec Corporation, and Supervising Engineer in the Space and Strategic Avionics Division at Honeywell. Mr. Dinger earned a Bachelor of Science in Mechanical Engineering from Cornell University and a Master of Science in Engineering Management from University of South Florida. He holds numerous device and method patents as inventor and has served on the Board of Directors for several privately held medical device companies and a faith-based charity. back to topback to top
DAVID FITZGERALD
President and Chief Executive Officer

David Fitzgerald became a director of the Company in April 2003 and President and Chief Executive Officer in February 2009. Mr. Fitzgerald spent twenty-five years in management positions at Pfizer, Inc., serving as President and Chief Executive Officer of its Howmedica division during his last fifteen years with the company, prior to retiring in 1996. Since his retirement, Mr. Fitzgerald has served as a Director for public companies such as: LifeCell Corporation from 2001 to 2008 and Chairman of Orthovita, Inc. from 2002 to 2009. He currently serves on the board of advisors of Sandvik MedTech, a contract manufacturer in the medical devices area. He holds a B.S. from American International College and a M.B.A. from New York University. back to topback to top
TODD  NEWTON
Executive Vice President, Chief Financial Officer and Chief Operating Officer

Todd Newton joined the Company in April 2009. Prior to joining ArthroCare, he served in various executive officer roles at Synenco Energy, Inc. from 2004 to 2008, including as President and Chief Executive Officer; President and Chief Operating Officer; and Executive Vice President and Chief Financial Officer. Before joining Synenco Energy, Mr. Newton served in various roles at Deloitte & Touche LLP from 1984 to 2004, including as partner from 1994 to 2004. Mr. Newton earned a Bachelor's Degree in Business Administration from the University of Texas at San Antonio. Mr. Newton is a member of the Texas State Society of Certified Public Accountants. In the past he has been a member of the Minnesota State Society of CPA's and the Pennsylvania Institute of CPA's. back to topback to top
JAMES PACEK
Senior Vice President, Global Markets and Sales Operations

James Pacek returned to ArthroCare in November 2006 as Vice-President and General Manager, Interventional Therapies. Mr. Pacek was named Senior Vice President, Strategic Business Units in December 2008 and Senior Vice President, Global Markets and Sales Operations in April 2011. He joined ArthroCare from the Sorin Group, where he held the position of President of ELA Medical. Mr. Pacek originally joined ArthroCare in October of 1999, as Managing Director and General Manager, AngioCare division. Prior to joining ArthroCare in 1999, Mr. Pacek held progressive sales, marketing and general management responsibilities with American Hospital Supply, Baxter, and Medtronic including a role as Vice President Business Unit Operations for Medtronic Europe. Mr. Pacek holds a Bachelors Degree in Business Administration from the University of Illinois. back to topback to top
BRUCE PROTHRO
Chief Regulatory Officer and Senior Vice President of Quality Systems and Assurance

Bruce Prothro joined the Company in October 1998 as Vice President, Regulatory Affairs and Quality Assurance. He served in this position until April 2002, when he became Vice President, Operational Planning, Quality and Regulatory Affairs. In November 2002, he became the Vice President and General Manager, Coblation Technologies and Regulatory Affairs. In May of 2010, Mr. Prothro was promoted to Chief Regulatory Officer and Senior Vice President, Quality Systems and Assurance. Prior to joining ArthroCare, Mr. Prothro was employed with KeraVision, Inc. and held positions of increasing responsibility including Director of Regulatory Affairs and Compliance. Mr. Prothro earned a B.S. degree in Chemistry from the University of California, Berkeley. back to topback to top
RICHARD W. REW, II
Senior Vice President, General Counsel, and Secretary

Richard Rew joined the Company in July 2006 as Vice President of Legal Affairs and was named Senior Vice President and General Counsel in December 2008. He joined ArthroCare from Activant Solutions Inc., a software and services company. Mr. Rew served as General Counsel of Activant beginning in 2000, became Secretary in 2002, and became Vice President, General Counsel & Secretary in 2005. Prior to Activant, he served as General Counsel for publicly traded EZCORP Inc. from 1996 to 2000. Mr. Rew holds a B.A., Plan II Honors Program from the University of Texas at Austin and a J.D. from the University of Oklahoma. Mr. Rew is a member of the State Bar of Texas. back to topback to top
SCOTT  SCHAFFNER
Sr Vice President and General Manager, Sports Medicine

Scott Schaffner joined the Company in January 2010 and currently is the Senior Vice president and General Manager, Sports Medicine. Prior to joining ArthroCare, Mr. Schaffner was employed by Zimmer Spine (originally Abbott Spine/Spinal Concepts) and held positions of increasing responsibility, from 2001 - 2009, including Group Product Manager, Director of Marketing, Division Vice President of Sales and Marketing and Division President. Scott also worked at Medtronic for nearly a decade from 1992 to 2001, in the company's Neurological and Cardiovascular businesses and consulted overseas with Deloitte & Touche. Scott earned a bachelor degree in business from the University of Minnesota in 1992 and a masters in business administration from Stanford University's Graduate School of Business in 1996. back to topback to top
GAYLE WILEY
Sr Vice President and Chief Human Resources Officer

Gayle Wiley joined the Company in September 2013. Before joining ArthroCare, Ms. Wiley was Vice President, HR for the CRV and the Emerging Markets businesses of Boston Scientific Corporation. Prior to that she served as Senior Vice President, Global Human Resources, Vignette Corporation, Austin, Texas, a leading web content management software company. Ms Wiley also worked for International Business Machines (IBM), where she served as an HR Executive for IBM’s European Software Group (Europe, Middle East and Africa), based in Paris, France for five years. Gayle has also held Human Resources positions of increasing responsibility for Tivoli Systems, Inc.; CompuCom Systems, Inc. and Abbott Laboratories. Gayle earned a BS and MS in Education from Henderson State University. back to topback to top
JEAN WOLOSZKO, M.D., PH.D.
Chief Technology Officer and Senior Vice President of Research and Development

Jean Woloszko joined the Company in 1998 as Medical Director and was promoted to Vice-President, Research and Development in 1999 and to his current position in 2010. Prior to joining ArthroCare, he served in various medical, research and academic positions in Europe and in the US. He also was principal manager of research and medical affairs at Medtronic. He holds a Doctorate in Bioengineering from the University of Illinois, Chicago and received his medical degree from the Université de Montpellier (France). He also holds a certification in Biomechanics and in Rehabilitation Medicine. back to topback to top
FABIANA LACERCA-ALLEN
Director

Fabiana Lacerca-Allen became a director of the Company in December 2013. Ms. Lacerca-Allen is currently the Chief Compliance Officer of Elan Corporation, plc, an Irish public company trading on the New York Stock Exchange and Irish Stock Exchange focusing on industry-leading neuroscience biotechnology. Over the last twenty years, she has held positions of increased responsibility where she managed legal and compliance matters globally, and as a senior executive has assisted in the delineation, implementation and execution of strategic initiatives. Previously she served from 2007 until 2010, as Senior Vice President and Chief Compliance Officer of Mylan, Inc., a global pharmaceutical company, and served, from 2004-2007, as Legal Compliance Director for Bristol-Myers Squibb Company, a global pharmaceutical company. In 2004, Ms. Lacerca-Allen was a Senior Lead Attorney for Microsoft Corporation, and from 1999-2004, she was the Director, Legal Affairs, Candean Region for Merck Sharp & Dohme. Ms. Lacerca-Allen has also held various positions with AT&T Capital, NBS Technologies, Karelia International Consulting, The University of California, McKenna & Cuneo, Karelia SRL, and the Industry of Commerce of Argentina. She holds a Law degree from the Universidad de Buenos Aires Law School, and a LLM from the University of California, Los Angeles, School of Law and maintains leadership positions in international lawyers and compliance organizations. The Board is nominating Ms. Lacerca-Allen to serve as a director due to her extensive experience implementing and managing global compliance and legal programs, including programs with periodic governmental certification requirements. back to topback to top
CHRISTIAN P. AHRENS
Director

Christian P. Ahrens became a director of the Company in September 2009. He is currently a Managing Director of One Equity Partners (OEP) and, prior to joining OEP in 2001, worked at Goldman Sachs. Mr. Ahrens currently serves on the board of directors of certain private portfolio companies of OEP. Mr. Ahrens received his A.B. from Princeton University. OEP is entitled to nominate as part of the slate of nominees recommended by the Board of Directors (and the Company will use its reasonable best efforts to have such nominees elected as members of the Board of Directors) two individuals to serve on the Board of Directors until the date on which OEP ceases to own at least 15 percent of the Company's voting securities. In addition, OEP is entitled as the holder of the Company's preferred stock to vote separately, to the exclusion of the holders of common stock, to elect two directors to the Company's Board of Directors. OEP has nominated Mr. Ahrens and the Board is nominating Mr. Ahrens to serve as a director due to his extensive capital markets experience. back to topback to top
GREGORY A. BELINFANTI
Director

Gregory A. Belinfanti became a director of the Company in September 2009. Mr. Belinfanti is currently a Managing Director of OEP and, prior to joining OEP in 2006, served as a Vice President in the Investment Banking division of Lehman Brothers, specializing in Global Healthcare. He currently serves on the board of directors of certain private portfolio companies of OEP. Mr. Belinfanti received his B.A. from New York University and his J.D. from Harvard Law School. OEP has nominated Mr. Belinfanti and the Board is nominating Mr. Belinfanti to serve as a director due to his extensive capital markets experience. back to topback to top
BARBARA D. BOYAN, PH.D.
Director

Barbara D. Boyan, Ph.D. became a director of the Company in March 2004. Beginning January 1, 2013, Dr. Boyan became Dean of the School of Engineering at the Virginia Commonwealth University in Richmond Virginia, where she also holds the William H. and Alice T. Goodwin Chair in Biomedical Engineering. From 2002 until 2012, Dr. Boyan was a Professor in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University, Georgia Institute of Technology in Atlanta, Georgia. During the same time frame, Dr. Boyan has also held the Price Gilbert, Jr. Chair in Tissue Engineering at the Georgia Institute of Technology. In 2012, Dr. Boyan was elected to the National Academy of Engineering. Dr. Boyan was Deputy Director for Research, Georgia Tech/Emory Center for Engineering of Living Tissues, Georgia Institute of Technology, until 2008 when she assumed the position of Associate Dean for Research and Innovation in Georgia Tech's College of Engineering. From 1981 to 2002, Dr. Boyan was Professor and Vice Chair for Research, Department of Orthopedics at the University of Texas Health Science Center at San Antonio, where she also served as Director, Industry University Cooperative Research Center and Director, Center for the Enhancement of the Biology/Biomaterials Interface. Dr. Boyan is a founder of Osteobiologics, Inc., an orthopedic device company that was acquired by Smith & Nephew. She also served on the board of directors of IsoTis, Inc. and presently serves on the boards of Carticept Medical, Inc and Cativa, Inc. Most recently, she founded SpherIngenics, Inc., a stem cell delivery company, and serves as its Chief Scientific Officer. Dr. Boyan is a consultant to several companies, including: Exactech, Inc.; Musculoskeletal Transplant Foundation; NuVasive, Inc.; Spineology, Inc.; Henry Schein, Inc.; Ace Medical, Inc; and Institut Straumann AG. Dr. Boyan has also served on the board of directors of various charitable and non-profit organizations, and educational institutions, including the International Conferences on the Chemistry and Biology of Mineralized Tissue, the International Conferences on the Growth Plate and the Dentistry Division of the American Association for the Advancement of Science. Dr. Boyan is also a member of the following committees of the American Academy of Orthopedic Surgeons: Women's Health Initiatives and the Orthopedic Device Forum. Dr. Boyan holds a B.A., M.A. and Ph.D. in biology from Rice University. The Board is nominating Dr. Boyan to serve as a director due to her extensive experience with medical device research, development and technology. back to topback to top
DAVID FITZGERALD
Director
President and Chief Executive Officer


David Fitzgerald became a director of the Company in April 2003 and President and Chief Executive Officer in February 2009. Mr. Fitzgerald spent twenty-five years in management positions at Pfizer, Inc., serving as President and Chief Executive Officer of its Howmedica division during his last fifteen years with the company, prior to retiring in 1996. Since his retirement, Mr. Fitzgerald has served as a Director for public companies such as: LifeCell Corporation from 2001 to 2008 and Chairman of Orthovita, Inc. from 2002 to 2009. He holds a B.S. from American International College and a M.B.A. from New York University. back to topback to top
JAMES G.  FOSTER
Director

James Foster became a director of the Company in August 2002. From December 1994 until he retired in June 2001, Mr. Foster was Vice President and General Manager of Medtronic Heart Valves, a division of Medtronic, Inc. From February 1984 to December 1994, Mr. Foster held various positions at Medtronic, including Vice President of Cardiac Surgery Sales & Strategic Planning in 1994, Vice President and General Manager of Medtronic Neurological Implantables from 1992 to 1994, Vice President and General Manager of Medtronic Interventional Vascular from 1990 to 1992 and Vice President and General Manager of Medtronic Blood Systems from 1984 to 1989. Mr. Foster was a director of LifeCell Corporation from March 1995 until it was acquired by KCI in June 2008. Mr. Foster holds a master's degree in management from the Sloan School at MIT and a B.S. from St. Joseph's University in Philadelphia. The Board is nominating Mr. Foster to serve as a director due to his extensive experience in medical technology sales and marketing, as well as business leadership experience. back to topback to top
TERRENCE E. GEREMSKI
Director
Director Since December 2006

Terrence Geremski became a director of the Company in December 2006. From 2001 to 2006, Mr. Geremski was Senior Vice President Finance and Chief Financial Officer of Carpenter Technology Corporation, an international manufacturer and distributor of specialty metals and engineered products. From 1992 to 2000, Mr. Geremski served as Executive Vice President and Chief Financial Officer as well as a Board member of Guilford Mills, Inc., a North Carolina-based international textile company. He also served as Vice President and Controller and various other management positions for Varity Corporation from 1979-1991. Mr. Geremski has also been an auditor and tax manager with Price Waterhouse in Chicago, IL and Toledo, OH. The Board is nominating Mr. Geremski to serve as a director due to his extensive finance, capital markets, public company reporting, and governance experience. back to topback to top
TORD B. LENDAU
Director

Tord Lendau became a director of the Company in June 2001. Mr. Lendau currently is on the Board of Directors of Vitrolife AB, a public limited liability company based in Sweden, specializing in systems to maintain human tissue outside of the body, focusing on fertility, transplantation and stem cell applications, and Folkia AS, a Norwegian private company specializing in small credit loans. From 2006 to 2010, Mr. Lendau was the General Manager of Sandvik MedTech AB, a contract manufacturer in medical devices. From 2003 to 2006, Mr. Lendau was the Chairman of Diamyd, a public Swedish biotech company focusing on the development of pharmaceuticals for the treatment of autoimmune diabetes and pain. From 2002 to 2006, Mr. Lendau was the Chief Executive Officer of Artimplant AB, a biomaterials company. From 1998 to 2002, Mr. Lendau was President of Noster Systems AB, a medical device company developing a system to detect the bacteria that causes stomach ulcers. From 1997 to 1998, he acted as President of ArthroCare Europe AB, overseeing the start-up of its international operations. Mr. Lendau was Vice President and General Manager of Medtronic/Synectics from 1996 to 1997 after the acquisition of Synectics Medical AB by Medtronic, Inc. Prior to this acquisition, from 1991 to 1996, Mr. Lendau was the CEO of Synectics Medical AB, a Swedish public company. Mr. Lendau studied in M.Sc. at Linköping University and has a B.S. degree in Electronics. The Board is nominating Mr. Lendau to serve as a director due to his extensive medical device industry management and directorship experience, as well as business acquisition experience. back to topback to top
PETER L. WILSON
Director

Peter Wilson became a director of the Company in June 2001. Mr. Wilson currently serves on the board of directors of Conceptus, Inc. a marketer of the Essure permanent birth control device. Mr. Wilson was President and Chief Executive Officer of Patient Education Systems from 1995 to 1998. Between 1992 and 1994, Mr. Wilson was an independent consultant in healthcare business development and marketing. From 1972 to 1992, Mr. Wilson worked for Procter & Gamble/Richardson Vicks, where he held various positions, including President of Richardson Vicks, Vice President/General Manager of Procter & Gamble Vicks Healthcare, President/General Manager of the Vidal Sassoon Division and President/General Manager of the Personal Care Division. Mr. Wilson holds an M.B.A. in marketing from Columbia University and a B.A. from Princeton University. The Board is nominating Mr. Wilson to serve as a director due to extensive directorship and product sales and marketing experience. back to topback to top